BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1532922)

  • 21. Functional interactions of aglycosylated monoclonal anti-D with Fc gamma RI+ and Fc gamma RIII+ cells.
    Leader KA; Kumpel BM; Hadley AG; Bradley BA
    Immunology; 1991 Apr; 72(4):481-5. PubMed ID: 1828055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells.
    Graziano RF; Fanger MW
    J Immunol; 1987 Nov; 139(10):3536-41. PubMed ID: 2960735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes.
    de Palazzo IG; Gercel-Taylor C; Kitson J; Weiner LM
    Cancer Res; 1990 Nov; 50(22):7123-8. PubMed ID: 2146012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of recombinant IFN-gamma (rIFN-gamma) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-gamma decreases inhibition by cytophilic human IgG and changes the cytolytic mechanism.
    Van Schie RC; Verstraten RG; Van de Winkel JG; Tax WJ; de Mulder PH
    J Immunol; 1992 Jan; 148(1):169-76. PubMed ID: 1530794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies.
    Karpovsky B; Titus JA; Stephany DA; Segal DM
    J Exp Med; 1984 Dec; 160(6):1686-701. PubMed ID: 6239899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of intracellular Ca2+ mobilization and cytotoxicity by hybrid mouse monoclonal antibodies. Fc gamma RII regulation of Fc gamma RI-triggered functions or signaling?
    Koolwijk P; Van de Winkel JG; Pfefferkorn LC; Jacobs CW; Otten I; Spierenburg GT; Bast BJ
    J Immunol; 1991 Jul; 147(2):595-602. PubMed ID: 1830069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32).
    Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW
    J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fc gamma R-mediated killing by eosinophils.
    Graziano RF; Looney RJ; Shen L; Fanger MW
    J Immunol; 1989 Jan; 142(1):230-5. PubMed ID: 2521234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of complement pathways by univalent antibody derivatives with intact Fc zones.
    Watts HF; Anderson VA; Cole VM; Stevenson GT
    Mol Immunol; 1985 Jul; 22(7):803-10. PubMed ID: 3849671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte Fc gamma receptor recognition of cell bound and aggregated IgG: effect of gamma-interferon.
    Ruiz P; Gomez F; Lopez R; Chien P; Rossman MD; Schreiber AD
    Am J Hematol; 1992 Apr; 39(4):257-63. PubMed ID: 1532472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including the Fc gamma R.
    Connor RI; Dinces NB; Howell AL; Romet-Lemonne JL; Pasquali JL; Fanger MW
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9593-7. PubMed ID: 1835086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.
    Repp R; Valerius T; Sendler A; Gramatzki M; Iro H; Kalden JR; Platzer E
    Blood; 1991 Aug; 78(4):885-9. PubMed ID: 1714327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies to human neutrophil Fc gamma RIII (CD16) identify polypeptide epitopes.
    Fleit HB
    Clin Immunol Immunopathol; 1991 May; 59(2):222-35. PubMed ID: 1706970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the zeta chain.
    O'Shea JJ; Weissman AM; Kennedy IC; Ortaldo JR
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):350-4. PubMed ID: 1703295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mechanisms of antibody-dependent killing mediated by lymphoid and myeloid cells are distinct based on different divalent cation requirements.
    Graziano RF; Erbe DV; Fanger MW
    J Immunol; 1989 Dec; 143(12):3894-900. PubMed ID: 2574205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phagocytosis mediated by three distinct Fc gamma receptor classes on human leukocytes.
    Anderson CL; Shen L; Eicher DM; Wewers MD; Gill JK
    J Exp Med; 1990 Apr; 171(4):1333-45. PubMed ID: 2139103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.
    Moretta A; Tambussi G; Bottino C; Tripodi G; Merli A; Ciccone E; Pantaleo G; Moretta L
    J Exp Med; 1990 Mar; 171(3):695-714. PubMed ID: 2137855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.
    Littaua R; Kurane I; Ennis FA
    J Immunol; 1990 Apr; 144(8):3183-6. PubMed ID: 2139079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chimeric univalent antibodies for treating lymphoid malignancies.
    Stevenson GT; Cole VM; Summerton J; Watts HF
    Med Oncol Tumor Pharmacother; 1984; 1(4):275-8. PubMed ID: 6544904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-linking of both types of IgG Fc receptors, Fc gamma RI and Fc gamma RII, enhances intracellular free Ca2+ in the monocytic cell line U937.
    van de Winkel JG; Tax WJ; Jacobs CW; Huizinga TW; Willems PH
    Scand J Immunol; 1990 Mar; 31(3):315-25. PubMed ID: 2157275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.